Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore and 12 more
International Journal of Infectious Diseases · 2021
doi:10.1016/j.ijid.2020.12.087 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The dissemination of COVID-19 around the globe has been followed by an increased consumption of antibiotics. This is related to the concern for bacterial superinfection in COVID-19 patients. The identification of bacterial pathogens is challenging in low and middle income countries (LMIC), as there are no readily-available and cost-effective clinical or biological markers that can effectively discriminate between bacterial and viral infections. Fortunately, faced with the threat of COVID-19 spread, there has been a growing awareness of the importance of antimicrobial stewardship programs, as well as infection prevention and control measures that could help reduce the microbial load and hence circulation of pathogens, with a reduction in dissemination of antimicrobial resistance. These measures should be improved particularly in developing countries. Studies need to be conducted to evaluate the worldwide evolution of antimicrobial resistance during the COVID-19 pandemic, because pathogens do not respect borders. This issue takes on even greater importance in developing countries, where data on resistance patterns are scarce, conditions for infectious pathogen transmission are optimal, and treatment resources are suboptimal.
Abstract licence: CC BY-NC-ND
References48
- 11.
- 12.
- 14.
- 31.
- 40.
35 more references, whose wording the paper’s licence keeps private.
All 48 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.